%0 Journal Article
%T Ventilator Associated Pneumonia in an Intensive Care Unit
%A Yadigar Yilmaz Camgoz
%A Ferda Yilmaz £¿nal
%A £¿znur £¿en
%J Open Journal of Respiratory Diseases
%P 44-55
%@ 2163-9418
%D 2022
%I Scientific Research Publishing
%R 10.4236/ojrd.2022.122004
%X The aim of this prospective study was to evaluate the incidence,
etiologic<span style=\"font-family:Verdana;\"> agents and mortality rate of ventilator-associated
pneumonia (VAP). In a six-</span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\">month
period, cases who were 18 years or older, dependent on mechanical ventilator
for more than 3 days and without pulmonary infection on first admission were
included in this study. In all cases, body temperature recordings, blood and
urine culture, microbiological analyses of endotracheal aspirates, and chest X-rays
were obtained and used to identify VAP. Apache II scores on admission, duration
of mechanical ventilation, length of intensive </span><span style=\"font-family:Verdana;\">care unit (ICU) stay and mortality were recorded. This study included 4</span><span style=\"font-family:Verdana;\">5
cases and 22 developed VAP (48%). The incidence of VAP was 25.34 per 1000
ventilator days. Univariate analyses showed that duration of mechanical
ventilation, length of ICU stay, coma and tracheotomy were associated with the
development of VAP. The mortality rate of cases with VAP (72.7%) was
significantly higher than cases without VAP (39.1%). The most frequent
microorganisms were </span><i><span style=\"font-family:Verdana;\">Acinetobacter </span></i><span style=\"font-family:Verdana;\">spp.,</span><i><span style=\"font-family:Verdana;\"> Pseudomonas aeruginosa and Klebsiella pneumoniae</span></i><span style=\"font-family:Verdana;\">. In our study, VAP
was a very common and important compli</span><span style=\"font-family:Verdana;\">cation
of mechanical ventilation and mortality was very high. To reduce</span><span style=\"font-family:Verdana;\"> mortality, minimize morbidity, shorten the length of stay, and reduce costs,
defined risk factors for VAP should be recognized and an effective infection
control program for the prevention of VAP should be implemented. Surveillance
results should be evaluated regularly and necessary precautions should be
taken.</span></span>
%K Ventilator Associated Pneumonia
%K Mechanical Ventilation
%K Intensive Care Unit
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=116553